The effect of july admission in the process of care of patients with acute cardiovascular conditions

Southern Medical Journal

Volumn 102, Issue 6, 2009, Pages 602-607

  Garcia, Santiago ^a   Canoniero, Mariana ^a   Young, Larry ^a  

^a VCRC ^*

Author keywords

Acute coronary syndromes; Congestive heart failure; Quality

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG UTILIZATION; EXPERIENCE; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATIENT CARE; PHYSICIAN; POSTOPERATIVE COMPLICATION; PREDICTION; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; CLINICAL COMPETENCE; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; INTERNSHIP AND RESIDENCY; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ADMISSION; QUALITY OF HEALTH CARE; TREATMENT OUTCOME;

EID: 68049126078     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181a2f8ca     Document Type: Article

References (30)

1. Brotherton SE, Rockey PH, Etzel SI. US graduate medical education, 2002-2003. JAMA 2003;290:1197-1202.
2. Rich EC, Gifford G, Luxenburg M, et al. The relationship of house staff experience to the cost and quality of inpatient care. JAMA 1990;263: 953-957. (Pubitemid 20061539)
3. Rich EC, Hillson SD, Dowd B, et al. Specialty differences in the "July Phenomenon" for twin cities teaching hospitals. Med Care 1993;31:73-83.
4. Shulkin DJ. The July phenomenon revisited: Are hospital complications associated with new house staff? Am J Med Qual 1995;10:14-17.
5. Chow KM, Szeto CC, Chan MH, et al. Near-miss errors in laboratory blood test requests by interns. QJM 2005;98:753-756.
6. Park SJ, Tector A, Piccioni W, et al. LVAD as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 2005;129:9-17.
7. Zuger A. Essay; it's July, the greenest month in Hospitals. No need to panic. Available at: http://query.nytimes.com/gst/fullpage.html? res=9E0DE6DF133EF934A35754C0A96E958260&scp=1&sq=july+ phenomenon+hospitals&st=nyt. Accessed on June 2, 2008.
8. Friedman R. Cases; their coats are white, but their hands are green. Available at: http://query.nytimes.com/gst/fullpage.html?res=980DE 0DA1438F93AA15755C0A9629C8B63&scp=2&sq=july+phenomenon+ hospitals&st=nyt. Accessed on June 2, 2008.
9. Finkielman JD, Morales J, Peters SG, et al. Mortality rate and length of stay of patients admitted to the intensive care unit. Crit Care Med 2004;32:1161-1165. (Pubitemid 38620985)
10. Barry WA, Rosenthal GE. Is there a July phenomenon? The effects of July admission on intensive care mortality and length of stay in teaching hospitals. J Gen Intern Med 2003;18:639-645.
11. Garcia S, Canoniero M, Peter A, et al. Correlation of TIMI Risk score with angiographic severity and extent of coronary artery disease in patients with non-ST segment elevation acute coronary syndromes. Am J Cardiol 2004;93:813-816. (Pubitemid 38429588)
12. Osorio J, Garcia S, Jimenez J. Cardiologists vs. Generalists in the management of acutely decompensated heart failure. J Card Fail 2005; 11(suppl):S180.
13. Antman E, Cohen M, Berninck P, et al. The TIMI risk score for unstable/ non-ST elevation MI. A method for prognostication and Therapeutic Decision Making. JAMA 2000;284:835-842. (Pubitemid 30643610)
14. Fonarow GC, AdamsKF Jr, Abraham WT, et al; ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005;293:572-580.
15. Braunwald E, Antman E, Beasley JW, et al. Management of patients with unstable angina and non-ST-segment elevation myocardial infarction update. Available at: http://www.acc.org/clinical/guidelines/ unstable/incorporated/ index.htm. Accessed on June 2, 2008.
16. Hunt SA, Abraham WT, Chin MH, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-e235.
17. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007. (Pubitemid 29271744)
18. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
19. Packer M, Coats AJ, Fowler MB, et al; Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-1658.
20. Packer M, Fowler MB, Roecker EB, et al; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002;106:2194-2199.
21. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
22. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asympatomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691.
23. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
24. Nicholls SJ, Tuzcu EM, Sipahi I, et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 2007;297: 499-508. (Pubitemid 46220805)
25. Cannon CP, Steinberg BA, Murphy SA, et al. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006;48:438-445. (Pubitemid 44109954)
26. Cannon CP, Battler A, Brindis RG, et al. ACC key elements and data definitions for measuring the clinical management and outcomes of patients with with acute coronary sundromes: a report of the American College of cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001;38: 2114-2130. (Pubitemid 33116592)
27. Fonarow GC, Yancy CW, Heywood JT; ADHERE scientific advisory committee, study group, and investigators. Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE registry. Arch Intern Med 2005;165:1469-1477.
28. Fonarow GC, LaBresh KA, Yancy CY, et al for the GWTG Steering Committee and Hospitals. Influence of the American heart Association's Get with the Guidelines heart failure (GWTG-HF) program on emerging performance measures for patients hospitalized with heart failure. Circulation 2006;114(suppl 2):572.
29. Albert NM, Birtcher KK, Cannon CP, et al. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the get with the guidelines database). Am J Cardiol 2008;101:1242-1246.
30. Hiratzka LF, Eagle KA, Liang L, et al; Get with the Guidelines Steering Committee. Atherosclerosis secondary prevention performance measures after coronary bypass surgery compared with percutaneous catheter intervention and nonintervention patients in the Get with the Guidelines database. Circulation 2007;116(11 suppl):I207-I212. (Pubitemid 47480792)